Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of 5-HT and fluoxetine on Turicibacter sanguinis gene expression in vitro

ABSTRACT: Effect of 5-HT and fluoxetine on Turicibacter sanguinis gene expression in vitro

PROVIDER: PRJNA552575 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Effect of 5-HT and fluoxetine on Turicibacter sanguinis gene expression in vitro

Project description:The overall goal of this study is the test the effect of 5-HT and fluoxetine on Turicibacter sanguinis gene expression in vitro

2019-07-04 | GSE133810 | GEO

Turicibacter sanguinis PC909

Project description:Turicibacter sanguinis PC909 genome sequencing project

| PRJNA42765 | ENA

Turicibacter sanguinis strain:K031

Project description:Turicibacter sanguinis strain:K031 Genome sequencing

| PRJNA714136 | ENA

Turicibacter sanguinis strain:MOL361

Project description:Turicibacter sanguinis strain:MOL361 Genome sequencing

| PRJNA610674 | ENA

Turicibacter sanguinis strain:DSM 14220

Project description:Turicibacter sanguinis DSM 14220 genome sequencing

| PRJNA500327 | ENA

Turicibacter sanguinis

Project description:Turicibacter sp. PC909 overview

| PRJNA42899 | ENA

Regulation of intestinal gene expression by Turicibacter sanguinis colonization in mice

Project description:The objective of this study is to determine whether monocolonization of germ-free mice with Turicibacter sangiunis results in changes in intestinal gene expression

2019-07-04 | GSE133809 | GEO

Regulation of intestinal gene expression by Turicibacter sanguinis colonization in mice

Project description:Regulation of intestinal gene expression by Turicibacter sanguinis colonization in mice

| PRJNA552571 | ENA

Brain transcriptome analysis of Arid1b heterozygote mutation and long-lasting effects of early chronic fluoxetine treatment for mutant mice [RNA-Seq]

Project description:Arid1b is a chromatin remodeler implicated in neurodevelopmental disorders. Arid1b mutant mice with haploinsufficiency (Arid1b HT) displayed persistent excitatory synaptic dysfunction from juvenile to adult stage, decreased synaptic density and transmission. Moreover, they showed autistic-like behaviors in both of early and adult stages, decreased sociability in pup USV calling and adult social interaction, and adult repetitive grooming. To investigate early transcriptomic changes in Arid1b mutant mice, RNAseq analysis of whole brain from wild-type and Arid1b mutant mice at postnatal day 10 was done. Transcriptomic changes support these electrophysiological and behavioral deficits. Arid1b HT mice at postnatal day 10 showed alterations in genes implicated in synaptic functions and ASD. Next, we found that early chronic fluoxetine treatment could carry out long-lasting restoration in electrophysiological and behavioral deficits in Arid1b HT mice. Whole brain transcriptomic analysis with mice at postnatal day 120 which underwent chronic fluoxetine treatment from postnatal day 3 to postnatal day 21 via mammillary milk was done to figure out transcriptomic reprogramming which contributes to this restoration. Comparing fluoxetine treated Arid1b HT mice and vehicle group, fluoxetine treated mice showed upregulation of synapse-related genes and disease related gene sets with reverse-ASD directions.

2022-07-21 | GSE189653 | GEO

Essential proteins' dynamics in Streptococcus sanguinis under antibiotic effect.

Project description:The current project investigates the proteomic profiles of essential genes, mass spectrometric analysis respectively, under impact of sub-inhibitory concentration of ampicillin (0.125 micro gm/ml), to elucidate the S. sanguinis stress response mechanisms on a temporal basis and define “pathogenesis signatures” as potential therapeutic targets. We further believe that the current findings will help characterize a bacterial model for studying the dynamics of essential genes under clinically relevant stress factors (antibiotic treatment) and assist in designing evidence-based guidelines for treatment in clinical settings.

2018-01-09 | PXD006479 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data